Related Experiment Video

Updated: Aug 12, 2026

Image-guided Convection-enhanced Delivery into Agarose Gel Models of the Brain
09:14

Image-guided Convection-enhanced Delivery into Agarose Gel Models of the Brain

Published on: May 14, 2014

[Efficiency of encefabol use in patients with dyscirculatory encephalopathy]

E N Panchenko, S E Kazakova, E F Safonova

    Likars'Ka Sprava
    |February 24, 2005
    PubMed

    Insights

    Encefabol treatment effectively improved vascular encephalopathy in older adults. Individualized dosing and psychodiagnostic tests are crucial for assessing treatment efficacy in patients with atherosclerotic and hypertensive conditions.

    Area of Science:

    • Neurology
    • Pharmacology

    Context:

    • Vascular encephalopathy affects individuals aged 56-68, often stemming from atherosclerosis and hypertension.
    • The study focuses on patients with stage I-III vascular encephalopathy.

    Purpose:

    • To evaluate the efficacy of Encefabol in treating vascular encephalopathy.
    • To substantiate the rationale for individualized Encefabol dosage.
    • To highlight the role of psychodiagnostic tests in assessing treatment outcomes.

    Summary:

    • This study investigated the effects of Encefabol on 50 patients (aged 56-68) diagnosed with vascular encephalopathy (stages I-III) caused by atherosclerosis and hypertension.
    • The research supports the administration of individually prescribed Encefabol doses.
    • Psychodiagnostic assessments were utilized to measure the effectiveness of Encefabol therapy.

    Impact:

    • The findings support the use of Encefabol as a treatment for vascular encephalopathy.
    • Highlights the importance of personalized medicine approaches in managing cerebrovascular diseases.
    • Emphasizes the utility of psychodiagnostic tools in clinical practice for evaluating treatment response.

    More Related Videos

    Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery08:22

    Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

    Published on: July 18, 2019

    Real-Time Dynamic Collection of Hippocampal Extracellular Fluid from Conscious Rats Using a Microdialysis System05:43

    Real-Time Dynamic Collection of Hippocampal Extracellular Fluid from Conscious Rats Using a Microdialysis System

    Published on: October 21, 2022

    Related Concept Videos

    Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

    Indirect-Acting Cholinergic Agonists: Pharmacological Actions

    Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
    At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
    Depolarizing Blockers: Pharmocokinetics01:19

    Depolarizing Blockers: Pharmocokinetics

    Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
    Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

    Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

    Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
    Electroconvulsive Therapy01:30

    Electroconvulsive Therapy

    Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
    Hepatic Encephalopathy01:29

    Hepatic Encephalopathy

    DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...